Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648).

Aiello S, Wells G, Stone EL, Kadri H, Bazzi R, Bell DR, Stevens MF, Matthews CS, Bradshaw TD, Westwell AD.

J Med Chem. 2008 Aug 28;51(16):5135-9. doi: 10.1021/jm800418z. Epub 2008 Jul 31.

PMID:
18666770
3.

Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.

Shi DF, Bradshaw TD, Wrigley S, McCall CJ, Lelieveld P, Fichtner I, Stevens MF.

J Med Chem. 1996 Aug 16;39(17):3375-84.

PMID:
8765521
4.

Synthesis, anti-breast cancer activity, and molecular modeling of some benzothiazole and benzoxazole derivatives.

Abdelgawad MA, Belal A, Omar HA, Hegazy L, Rateb ME.

Arch Pharm (Weinheim). 2013 Jul;346(7):534-41. doi: 10.1002/ardp.201300044. Epub 2013 Jun 5.

PMID:
23740859
5.

Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles.

Kashiyama E, Hutchinson I, Chua MS, Stinson SF, Phillips LR, Kaur G, Sausville EA, Bradshaw TD, Westwell AD, Stevens MF.

J Med Chem. 1999 Oct 7;42(20):4172-84.

PMID:
10514287
6.

Synthesis and anticancer evaluation of bis(benzimidazoles), bis(benzoxazoles), and benzothiazoles.

Huang ST, Hsei IJ, Chen C.

Bioorg Med Chem. 2006 Sep 1;14(17):6106-19. Epub 2006 May 22.

PMID:
16714116
7.

Synthesis and antitumour evaluation of novel 2-phenylbenzimidazoles.

Kadri H, Matthews CS, Bradshaw TD, Stevens MF, Westwell AD.

J Enzyme Inhib Med Chem. 2008 Oct;23(5):641-7. doi: 10.1080/14756360802205398 .

PMID:
18821253
8.

Novel benzothiazole, benzimidazole and benzoxazole derivatives as potential antitumor agents: synthesis and preliminary in vitro biological evaluation.

Xiang P, Zhou T, Wang L, Sun CY, Hu J, Zhao YL, Yang L.

Molecules. 2012 Jan 17;17(1):873-83. doi: 10.3390/molecules17010873.

9.

2-(4-aminophenyl) benzothiazole: a potent and selective pharmacophore with novel mechanistic action towards various tumour cell lines.

Dubey R, Shrivastava PK, Basniwal PK, Bhattacharya S, Moorthy NS.

Mini Rev Med Chem. 2006 Jun;6(6):633-7. Review.

PMID:
16787373
10.

Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles.

Hutchinson I, Chua MS, Browne HL, Trapani V, Bradshaw TD, Westwell AD, Stevens MF.

J Med Chem. 2001 Apr 26;44(9):1446-55.

PMID:
11311068
11.

Antitumour benzothiazoles. Part 20: 3'-cyano and 3'-alkynyl-substituted 2-(4'-aminophenyl)benzothiazoles as new potent and selective analogues.

Hutchinson I, Bradshaw TD, Matthews CS, Stevens MF, Westwell AD.

Bioorg Med Chem Lett. 2003 Feb 10;13(3):471-4.

PMID:
12565953
12.

Synthesis, structure-activity relationships and preliminary antitumor evaluation of benzothiazole-2-thiol derivatives as novel apoptosis inducers.

Wang Z, Shi XH, Wang J, Zhou T, Xu YZ, Huang TT, Li YF, Zhao YL, Yang L, Yang SY, Yu LT, Wei YQ.

Bioorg Med Chem Lett. 2011 Feb 15;21(4):1097-101. doi: 10.1016/j.bmcl.2010.12.124. Epub 2010 Dec 31.

PMID:
21262571
13.

Evaluation of Re and (99m)Tc complexes of 2-(4'-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals.

Tzanopoulou S, Sagnou M, Paravatou-Petsotas M, Gourni E, Loudos G, Xanthopoulos S, Lafkas D, Kiaris H, Varvarigou A, Pirmettis IC, Papadopoulos M, Pelecanou M.

J Med Chem. 2010 Jun 24;53(12):4633-41. doi: 10.1021/jm1001293.

PMID:
20518489
14.

A new approach to the synthesis of benzothiazole, benzoxazole, and pyridine nucleosides as potential antitumor agents.

Khodair AI, Al-Masoudi NA, Gesson JP.

Nucleosides Nucleotides Nucleic Acids. 2003 Nov;22(11):2061-76.

PMID:
14680028
15.

Synthesis and evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1.

Kumar D, Jacob MR, Reynolds MB, Kerwin SM.

Bioorg Med Chem. 2002 Dec;10(12):3997-4004.

PMID:
12413851
16.

Synthesis and biological evaluation of mercapto triazolo-benzothiadiazine linked aminobenzothiazoles as potential anticancer agents.

Kamal A, Khan MN, Srikanth YV, Rajesh SV.

Chem Biol Drug Des. 2009 Jun;73(6):687-93. doi: 10.1111/j.1747-0285.2009.00815.x.

PMID:
19635062
17.

Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents.

Yoshida M, Hayakawa I, Hayashi N, Agatsuma T, Oda Y, Tanzawa F, Iwasaki S, Koyama K, Furukawa H, Kurakata S, Sugano Y.

Bioorg Med Chem Lett. 2005 Jul 15;15(14):3328-32.

PMID:
15955697
18.

A SAR study of novel antiproliferative ruthenium and osmium complexes with quinoxalinone ligands in human cancer cell lines.

Ginzinger W, Mühlgassner G, Arion VB, Jakupec MA, Roller A, Galanski M, Reithofer M, Berger W, Keppler BK.

J Med Chem. 2012 Apr 12;55(7):3398-413. doi: 10.1021/jm3000906. Epub 2012 Mar 27.

PMID:
22417128
19.

2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor.

Bazzi R, Bradshaw TD, Rowlands JC, Stevens MF, Bell DR.

Toxicol Appl Pharmacol. 2009 May 15;237(1):102-10. doi: 10.1016/j.taap.2009.02.015. Epub 2009 Mar 2.

PMID:
19265716
20.

Synthesis of some novel benzoxazole derivatives as anticancer, anti-HIV-1 and antimicrobial agents.

Rida SM, Ashour FA, El-Hawash SA, ElSemary MM, Badr MH, Shalaby MA.

Eur J Med Chem. 2005 Sep;40(9):949-59.

PMID:
16040162

Supplemental Content

Support Center